GALAXY AND COLLABORATIVE PUBLICATIONS

Kim KJ, Wang L, Su YC, Gillespie GY, Salhotra A, Lal B, Laterra J.  Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.  Clin Cancer Res 12: 1292-1298, 2006.

Binning MJ, Niazi T, Pedone CA, Lal B, Eberhart CG, Kim KJ, Laterra J, Fults DW  Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.  Cancer Res 68: 7838-45, 2008.

Stabile LP, Rothstein ME, Keohavong P, Jin J, Yin J, Land SR, Dacic S, Luong TM, Kim KJ, Dulak AM, Siegfried JM.  Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis.  Mol Cancer Ther 7:1913-1922, 2008.

Lal B, Goodwin CR, Sang Y, Foss CA, Cornet K, Muzamil S, Pomper MG, Kim KJ, Laterra J. EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts. Mol Cancer Ther 8:1751-1760, 2009.

Zhao W-m, Wang L, Park H, Chhim S, Tanphanich M, Yashiro M, and Kim KJ. Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts. Clin Cancer Res 16:5750-5820, 2010.

Coon V, Laukert T, Pedone CA, Laterra J, Kim KJ, Fults DW. Molecular Therapy Targeting Sonic Hedgehog and Hepatocyte Growth Factor Signaling in a Mouse Model of Medulloblastoma. Mol Cancer Ther 9:2627-2636, 2010.

Wang, L., Park, H., Chhim, S., Ding, Y., Jiang, W., Queen, C., Kim, K.J. A novel monoclonal antibody to fibroblast growth factor 2 effectively inhibits growth of hepatocellular carcinoma xenografts. Mol. Cancer Ther 11: 864-872, 2012.